Edesa Biotech, Inc.

NASDAQ:EDSA

Biotechnology

Healthcare
$5.75 +1.31%

+$0.09 today

Market cap
$55.39M
Beta
1.07
P/E (TTM)
-5.5
EPS (TTM)
-$1.27
52W Low $0.72High $20.32

Volume 0.07M

Average 0.62M

EDSA EBITDA Margin

EBITDA as a percentage of revenue.

Edesa Biotech, Inc.NASDAQ: EDSA

EBITDA Margin · Q2 FY2026 · quarter ended Mar 2026

EBITDA Margin not reported for Q2 FY2026

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
—— QoQ
Last fiscal yearSep 2025
—— YoY
LTMMar 2026
—— YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3 years———
5 years——
10 years——

EBITDA Margin history

Percent of revenue · from the income statement

No EBITDA Margin data reported for this period type.

EBITDA Margin vs competitors

How EDSA compares with its peers on the latest reported figures

No competitor EBITDA Margin figures are available to compare.

Income Statement

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue00000
Cost of Revenue118.79K118.19K183.47K186.05K119.27K
Gross Profit(118.79K)(118.19K)(183.47K)(186.05K)(119.27K)
Gross Margin—————
Research & Development17.95M13.34M4.79M2.88M3.67M
Selling, General & Admin5.73M5.04M4.43M4.13M4.24M
Operating Expenses23.68M18.37M9.22M7.01M7.79M
Depreciation & Amortization118.79K118.19K183.47K186.05K119.27K
EBITDA(13.22M)(17.43M)(8.19M)(5.98M)(7.07M)
EBITDA Margin—————
Operating Income(23.68M)(18.37M)(9.22M)(7.01M)(7.91M)
Operating Margin—————
Interest Income11.17K64289.85K153.5K2.56K
Interest Expense00000
Other Income / Expenses10.34M822.67K849.14K845.5K726.84K
Income Before Tax(13.34M)(17.55M)(8.37M)(6.17M)(7.18M)
Pre-Tax Margin—————
Income Tax Expense800800800800800
Net Income(13.34M)(17.55M)(8.37M)(6.17M)(7.19M)
Net Margin—————
EPS (Basic)(7.74)(8.37)(2.93)(1.93)(1.27)
EPS (Diluted)(7.73)(8.37)(2.93)(1.93)(1.27)
Weighted Avg Shares1.73M2.1M2.86M3.2M5.68M
Weighted Avg Shares (Diluted)1.73M2.1M2.86M3.2M5.68M

Edesa Biotech, Inc.

NASDAQ:EDSA

Intrinsic Alpha fair value

Locked

Current Price

$5.75

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.